Cardinal Health   Report issue

Academic/Hospital Phase 2
Founded: Dublin OH United States (1971)

Organization Overview

First Clinical Trial
2015
NCT02509598
First Marketed Drug
1981
technetium tc-99m medronate kit
First NDA Approval
None
Last Known Activity
2019

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

Cardinal Health | CARDINAL HEALTH 414 | Cardinal Health 414, LLC | CARDINAL HEALTH 418 | CARDINAL HLTH 414

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Anus Neoplasms (Phase 2)

Melanoma (Phase 2)

Myalgia (Phase 2)

Rhabdomyosarcoma (Phase 2)

Uterine Cervical Neoplasms (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 4
  • # of Trial APIs: 3